Massimo Squatrito

9PUBLICATIONS
63CO-AUTHORS
Molecular targetsPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 13, 2025
Cambridge Neoadjuvant Cancer of the Prostate (CANCAP03): A Window Study into the Effects of Olaparib ± Degarelix in Primary Prostate Cancer.

Harveer Dev, Mark Linch, Krishna Narahari

|Jan 02, 2025
A new effLuc/Kate dual reporter allele for tumor imaging in mice.

Latifa Bakiri, Mélanie Tichet, Carolina Marques

|Aug 06, 2020
MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas.

Barbara Oldrini, Nuria Vaquero-Siguero, Quanhua Mu

|Jun 14, 2020
A kinase-deficient NTRK2 splice variant predominates in glioma and amplifies several oncogenic signaling pathways.

Siobhan S Pattwell, Sonali Arora, Patrick J Cimino

|Jun 13, 2019
LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8<sup>+</sup> T cell tumor-infiltration impairing anti-PD1 therapy.

Mónica Pascual-García, Ester Bonfill-Teixidor, Ester Planas-Rigol

Pageof 2